. Author manuscript; available in PMC: 2016 Oct 1.

Published in final edited form as: J Dev Behav Pediatr. 2015 Oct;36(8):620–627. doi: 10.1097/DBP.0000000000000178

Table 3.

Adjusted associations between psychosocial risk indices and detection of cervical HPV^*

	HPV DNA Group Types^‡
Psychosocial risk indices	Any-type^a	P	High risk-types^b	p	Vaccine-types	p
Unweighted index	1.10 (1.01,1.21)	0.037	1.09 (.98,1.21)	0.097	1.11 (.92,−1.34)	0.282
Weighted index (binary scale)	1.16 (1.00,1.35)	0.056	1.13 (0.96,1.33)	0.150	1.25 (0.92,1.70)	0.148
Weighted index (original scale)	1.19 (1.02,1.39)	0.024	1.14 (0.97,1.34)	0.115	1.49 (1.12,2.00)	0.007
Weighted index (original scale eight variables)^†	1.08 (0.92, 1.27)	0.345	1.11 (0.93, 1.31)	0.234	1.42 (1.05, 1.94)	0.024
Number of recent partners	1.21 (1.06, 1.37)	0.002	1.04(0.93, 1.17)	0.446	1.09 (0.91, 1.32)	0.350

Pooled adjusted odd ratios (OR) and 95% confidence intervals (CI) across multiple imputation datasets are shown for a unit increase in psychosocial risk index score, adjusted for age, ethnicity, history of chlamydia, and vaccination dose.

^†

Adjusted OR for weighted index based on 8 index variables and number of recent partners modeled as separate variable (also shown).

^‡

HPV outcomes:

Any-type.

High risk-types: 16,18,31,33,35,39,45,51,52,56,58,59.

^c HPV4 vaccine-types: 6,11,16,18.